Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov;37(11):1355-1369.
doi: 10.1007/s40273-019-00819-z.

Transparency in Decision Modelling: What, Why, Who and How?

Affiliations
Review

Transparency in Decision Modelling: What, Why, Who and How?

Christopher James Sampson et al. Pharmacoeconomics. 2019 Nov.

Abstract

Transparency in decision modelling is an evolving concept. Recently, discussion has moved from reporting standards to open-source implementation of decision analytic models. However, in the debate about the supposed advantages and disadvantages of greater transparency, there is a lack of definition. The purpose of this article is not to present a case for or against transparency, but rather to provide a more nuanced understanding of what transparency means in the context of decision modelling and how it could be addressed. To this end, we review and summarise the discourse to date, drawing on our collective experience. We outline a taxonomy of the different manifestations of transparency, including reporting standards, reference models, collaboration, model registration, peer review and open-source modelling. Further, we map out the role and incentives for the various stakeholders, including industry, research organisations, publishers and decision makers. We outline the anticipated advantages and disadvantages of greater transparency with respect to each manifestation, as well as the perceived barriers and facilitators to greater transparency. These are considered with respect to the different stakeholders and with reference to issues including intellectual property, legality, standards, quality assurance, code integrity, health technology assessment processes, incentives, funding, software, access and deployment options, data protection and stakeholder engagement. For each manifestation of transparency, we discuss the 'what', 'why', 'who' and 'how'. Specifically, their meaning, why the community might (or might not) wish to embrace them, whose engagement as stakeholders is required and how relevant objectives might be realised. We identify current initiatives aimed to improve transparency to exemplify efforts in current practice and for the future.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:. Manifestations of transparency
Note: the positioning of the manifestations is illustrative and not a generalisable ranking of the expected impact of any manifestation of transparency in the context of a given model.
Figure 2:
Figure 2:. The benefits and risks of greater transparency
Figure 3:
Figure 3:. Stakeholders in decision modelling

References

    1. Daniels N, Sabin J. Limits to Health Care: Fair Procedures, Democratic Deliberation, and the Legitimacy Problem for Insurers. Philosophy & Public Affairs. 1997;26:303–50. - PubMed
    1. Daniels N, Sabin JE. Accountability for Reasonableness. Setting Limits Fairly: Can we learn to share medical resources? Oxford University Press; 2002.
    1. Eddy DM, Hollingworth W, Caro JJ, Tsevat J, McDonald KM, Wong JB. Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force–7. Medical Decision Making. 2012;32:733–43. - PubMed
    1. Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, et al. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess. 2004;8:iii–iv, ix–xi, 1–158. - PubMed
    1. Sampson CJ, Wrightson T. Model Registration: A Call to Action. PharmacoEconomics - Open. 2017;1:73–7. - PMC - PubMed

Publication types

LinkOut - more resources